Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis From Breast Cancer

NCT05286684 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT05286684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis From Breast Cancer
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Completed
Start date
January 4, 2023
Completion date
November 15, 2023
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer